Merck’s drug for diabetes-related eye disease shows promise in trial
Merck’s drug for diabetes-related eye disease shows promise in trial Merck MRK.N said on Thursday its injectable drug to treat a serious eye disease affecting diabetes patients met the main goal in a mid- to late-stage trial.